Neurogenesis and gliogenesis modulation in cerebral ischemia by CDK5 RNAi-based therapy

Neurogenesis and gliogenesis modulation in cerebral ischemia by CDK5 RNAi-based therapy

Introduction: Cerebral ischemia is the third cause of death risk in Colombia and the first cause of physical disability worldwide. Different studies on the silencing of the cyclin-dependent kinase 5 (CDK5) have shown that reducing its activity is beneficial in ischemic contexts. However, its effect...

Full description

Bibliographic Details
Main Authors:	Juan Ignacio Muñoz-Manco, Johanna Andrea Gutiérrez-Vargas, Gloria Patricia Cardona-Gómez
Format:	Article
Language:	English
Published:	Instituto Nacional de Salud 2018-09-01
Series:	Biomédica: revista del Instituto Nacional de Salud
Subjects:	Brain ischemia neurogenesis cyclin-dependent kinase 5
Online Access:	https://www.revistabiomedica.org/index.php/biomedica/article/view/3800

Similar Items

Mouse Model of Congenital Heart Defects, Dysmorphic Facial Features and Intellectual Developmental Disorders as a Result of Non-functional CDK13
by: Monika Nováková, et al.
Published: (2019-08-01)

Sub-cloning of cyclin-dependent kinase 3 (CDK3) gene into a mammalian expression vector /
by: Alnaseri, Zubaida Talal M., 1996-, author 614711
Published: (2018)

Sub-cloning of cyclin-dependent kinase 3 (CDK3) gene into a mammalian expression vector /
by: Alnaseri, Zubaida Talal M., 1996-, author 614711, et al.
Published: (2018)

A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1
by: Pinhero Reena, et al.
Published: (2004-01-01)

Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes
by: Lifei Wang, et al.
Published: (2023-12-01)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
by: Navid Sobhani, et al.
Published: (2019-04-01)

Docking to a Basic Helix Promotes Specific Phosphorylation by G1-Cdk1
by: Ilona Faustova, et al.
Published: (2021-09-01)

Inhibition of Mitochondrial Antioxidant Defense and CDK4/6 in Mesothelioma
by: Marian Kratzke, et al.
Published: (2023-05-01)

Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review
by: Paweł Łukasik, et al.
Published: (2021-03-01)

An In Silico Approach for Potential Natural Compounds as Inhibitors of Protein CDK1/Cks2
by: Abu Saim Mohammad Saikat
Published: (2021-11-01)

CDK Regulation of Meiosis: Lessons from <i>S. cerevisiae</i> and <i>S. pombe</i>
by: Anne M. MacKenzie, et al.
Published: (2020-06-01)

Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior
by: Alan Umfress, et al.
Published: (2022-05-01)

EmCyclinD-EmCDK4/6 complex is involved in the host EGF-mediated proliferation of Echinococcus multilocularis germinative cells via the EGFR-ERK pathway
by: Chonglv Feng, et al.
Published: (2022-08-01)

A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors
by: Mariane Teodoro Fernandes, et al.
Published: (2018-11-01)

Expression of cyclooxygenase-2(COX-2) and cyclin dependent kinase 1B (CDKN1B/p27Kip1⁯) in human prostatet adenocarcinoma
by: Md Roduan, Mohd Rohaizad
Published: (2011)

Lappaol F regulates the cell cycle by activating CDKN1C/p57 in human colorectal cancer cells
by: Rui-Yi Yang, et al.
Published: (2023-12-01)

Cdk5 Phosphorylates a Component of the HDAC Complex and Regulates Histone Acetylation during Neuronal Cell Death
by: Amy K.Y. Fu, et al.
Published: (2012-03-01)

Safety of CDK4/6 Inhibitors Combined with Radiotherapy in Patients with Metastatic Breast Cancer: A Review of the Literature
by: Rejane Franco, et al.
Published: (2023-06-01)

Explaining Redundancy in CDK-Mediated Control of the Cell Cycle: Unifying the Continuum and Quantitative Models
by: Daniel Fisher, et al.
Published: (2022-06-01)

Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation
by: Naim A. Khan, et al.
Published: (2006-10-01)

New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches
by: Aisha A. Alsfouk, et al.
Published: (2023-07-01)

In vivo PET Imaging of Gliogenesis After Cerebral Ischemia in Rats
by: María Ardaya, et al.
Published: (2020-07-01)

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions
by: Rossana Roncato, et al.
Published: (2020-09-01)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021-05-01)

Development of CDK4/6 Inhibitors: A Five Years Update
by: Alessandra Ammazzalorso, et al.
Published: (2021-03-01)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
by: Wang D, et al.
Published: (2022-02-01)

Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27
by: Betheney R. Pennycook, et al.
Published: (2021-11-01)

Cyclin A/Cdk1 modulates Plk1 activity in prometaphase to regulate kinetochore-microtubule attachment stability
by: Ana Maria G Dumitru, et al.
Published: (2017-11-01)

Multiple cutaneous melanomas associated with gastric and brain metastases
by: Lara Caroline Grander, et al.
Published: (2016-10-01)

Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice
by: Benjamin Thilo Krüger, et al.
Published: (2022-02-01)

Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice.
by: Yukio eYamamura, et al.
Published: (2013-02-01)

Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease
by: Olivia Engmann, et al.
Published: (2009-05-01)

Cyclin B Export to the Cytoplasm via the Nup62 Subcomplex and Subsequent Rapid Nuclear Import Are Required for the Initiation of <i>Drosophila</i> Male Meiosis
by: Kanta Yamazoe, et al.
Published: (2023-11-01)

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
by: Francesco Schettini, et al.
Published: (2018-12-01)

Proliferation rate and differentiation potential are independent during the transition from neurogenesis to gliogenesis in the mouse embryonic spinal cord
by: Leonora Olivos-Cisneros, et al.
Published: (2021-06-01)

Structural insights into the functional diversity of the CDK–cyclin family
by: Daniel J. Wood, et al.
Published: (2018-09-01)

A kinase of many talents: non-neuronal functions of CDK5 in development and disease
by: Samanta Sharma, et al.
Published: (2020-01-01)

Exploring cell cycle-mediated regulations of glycolysis in budding yeast
by: Yanfei Zhang, et al.
Published: (2023-10-01)

TAT‐LBD‐Ngn2‐improved cognitive functions after global cerebral ischemia by enhancing neurogenesis
by: Bin Feng, et al.
Published: (2023-01-01)

Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia
by: Jialei Yang, et al.
Published: (2017-06-01)